BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33554914)

  • 1. Peripheral Markers of Neurovascular Unit Integrity and Amyloid-β in the Brains of Menopausal Women.
    Jayachandran M; Miller VM; Lahr BD; Bailey KR; Lowe VJ; Fields JA; Mielke MM; Kantarci K
    J Alzheimers Dis; 2021; 80(1):397-405. PubMed ID: 33554914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep quality and cortical amyloid-β deposition in postmenopausal women of the Kronos early estrogen prevention study.
    Zeydan B; Lowe VJ; Tosakulwong N; Lesnick TG; Senjem ML; Jack CR; Fields JA; James TT; Gleason CE; Dowling NM; Miller VM; Kantarci K
    Neuroreport; 2021 Mar; 32(4):326-331. PubMed ID: 33470769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.
    Kantarci K; Lowe VJ; Lesnick TG; Tosakulwong N; Bailey KR; Fields JA; Shuster LT; Zuk SM; Senjem ML; Mielke MM; Gleason C; Jack CR; Rocca WA; Miller VM
    J Alzheimers Dis; 2016 May; 53(2):547-56. PubMed ID: 27163830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal hormone therapy, blood thrombogenicity, and development of white matter hyperintensities in women of the Kronos Early Estrogen Prevention Study.
    Jayachandran M; Lahr BD; Bailey KR; Miller VM; Kantarci K
    Menopause; 2020 Mar; 27(3):305-310. PubMed ID: 31934946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial.
    Kantarci K; Tosakulwong N; Lesnick TG; Zuk SM; Lowe VJ; Fields JA; Gunter JL; Senjem ML; Settell ML; Gleason CE; Shuster LT; Bailey KR; Dowling NM; Asthana S; Jack CR; Rocca WA; Miller VM
    Neurology; 2018 Apr; 90(16):e1404-e1412. PubMed ID: 29661902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of hormone therapy on serotonin, vascular function and mood in the KEEPS.
    Raz L; Hunter LV; Dowling NM; Wharton W; Gleason CE; Jayachandran M; Anderson L; Asthana S; Miller VM
    Climacteric; 2016; 19(1):49-59. PubMed ID: 26652904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: follow-up from the Kronos Early Estrogen Prevention Study.
    Miller VM; Hodis HN; Lahr BD; Bailey KR; Jayachandran M
    Menopause; 2019 Jan; 26(1):24-31. PubMed ID: 30020254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of menopausal hormone therapy on proteins associated with senescence and inflammation.
    Faubion L; White TA; Peterson BJ; Geske JR; LeBrasseur NK; Schafer MJ; Mielke MM; Miller VM
    Physiol Rep; 2020 Aug; 8(16):e14535. PubMed ID: 32857481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial function in women of the Kronos Early Estrogen Prevention Study.
    Kling JM; Lahr BA; Bailey KR; Harman SM; Miller VM; Mulvagh SL
    Climacteric; 2015 Apr; 18(2):187-97. PubMed ID: 25417709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High performance plasma amyloid-β biomarkers for Alzheimer's disease.
    Nakamura A; Kaneko N; Villemagne VL; Kato T; Doecke J; Doré V; Fowler C; Li QX; Martins R; Rowe C; Tomita T; Matsuzaki K; Ishii K; Ishii K; Arahata Y; Iwamoto S; Ito K; Tanaka K; Masters CL; Yanagisawa K
    Nature; 2018 Feb; 554(7691):249-254. PubMed ID: 29420472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
    Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
    JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy.
    Cintron D; Beckman JP; Bailey KR; Lahr BD; Jayachandran M; Miller VM
    Maturitas; 2017 May; 99():59-65. PubMed ID: 28364870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
    Bhavnani BR
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles.
    Miller VM; Lahr BD; Bailey KR; Heit JA; Harman SM; Jayachandran M
    Platelets; 2016; 27(1):32-42. PubMed ID: 25856160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.
    Reginster JY; Christiansen C; Dequinze B; Deroisy R; Gaspard U; Taquet AN; Franchimont P
    Calcif Tissue Int; 1993 Jul; 53(1):13-6. PubMed ID: 8394191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Rodriguez JL; Snellman A; Suárez-Calvet M; Zetterberg H; Blennow K; Schöll M;
    Brain; 2021 Feb; 144(1):325-339. PubMed ID: 33257949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.